Crystal Pharmatech
● Listed in the last 48hAbout the organisation
Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. Established in 2010 and have R&D centers located in Suzhou (China), New Jersey, San Francisco (USA), and Toronto (Canada). Also its key differentiator is integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.
What the listing means
Crystal Pharmatech appeared on the Eclipse leak site on 23 August 2026. Groups publish a victim once negotiations stall or as pressure during them, so a listing usually means data was already exfiltrated — the attack itself is dated 21 August 2026, 2 days before the listing. This group has published 2 claims in the last 30 days and remains active.
Recommended actions
- Treat any unsolicited message referencing Crystal Pharmatech as suspicious — leaked data gets weaponised for phishing within days.
- If you hold an account on www.crystalpharmatech.com, change that password now, update it anywhere you reused it, and enable two-factor authentication.
- Other Healthcare organisations should review this group's known TTPs and validate detection coverage against them.
- Watch for follow-on extortion: stolen data is often re-leaked or resold after the initial listing.
- A leak-site listing is a claim made by the attacker, not a confirmed breach — check the organisation's own disclosures before acting on it.
Leak-site evidence
Listing URL https://www.ransomware.live/id/Q3J5c3RhbCBQaGFybWF0ZWNoQEVjbGlwc2U=
Show leak-site screenshot
Captured from the group's extortion site. It may contain the victim's data or the attacker's messaging.
